Wild Bioscience
Category: AI in Agriculture
Wild Bioscience uses AI-powered precision breeding to develop climate-resilient, high-yield crop varieties by harnessing beneficial genetic traits from wild plants. Wild Bioscience was founded in 2021. The company is led by Ross Hendron. Based in Oxford, United Kingdom. Team size: 30. Total funding raised: $60 million. Latest round: Series A. Key investors include Ellison Institute of Technology (lead investor), Oxford Science Enterprises, Braavos Capital, University of Oxford.
- Founded
- 2021
- Headquarters
- Oxford, United Kingdom
- Team size
- 30
- Total funding
- $60 million
Value proposition
Create climate-resilient, high-yield crops that increase farm productivity and food security while reducing environmental footprint through AI-driven precision breeding
Products and solutions
AI-powered precision breeding platform, Enhanced crop varieties with drought resistance, disease tolerance, and increased yield, Carbon sequestration technologies through modified plants
Unique value
Uses AI to decode evolutionary insights from wild plant species and transfer beneficial traits to commercial crops, focusing on photosynthesis enhancement and climate resilience
Target customer
Farmers, seed companies, and large agricultural enterprises seeking to improve crop resilience and yield
Industries served
Agriculture, AgTech, Biotechnology, Climate Technology
Technology advantage
Proprietary AI-driven genomics platform that combines computational biology with precision breeding to rapidly identify and integrate valuable traits from wild plants into crops, accelerating development compared to traditional breeding
How they differentiate
Unique approach using AI to discover beneficial genetic traits from wild relatives of crops, enhancing climate resilience and yield through precision breeding rather than traditional GMO approaches
Main competitors
Inari Agriculture, Benson Hill, Pairwise Plants
Key partnerships
University of Oxford (spinout), Oxford Science Enterprises, Ellison Institute of Technology (lead investor), Braavos Capital
Major milestones
Successfully spun out of University of Oxford in 2021, Secured $60 million Series A funding in October 2025, Grown team to 30 employees, Advanced AI-driven platform for identifying genetic traits from wild plants, Field trials of enhanced crop varieties across four countries
Growth metrics
Team of 30 employees, field trials across four countries, AI platform processing genetic data from wild plants
Market positioning
Research-intensive ag-tech startup developing next-generation climate-smart crops, positioned as AI-first approach to agricultural innovation
Geographic focus
UK and European markets primarily, with global expansion through field trials in four countries
Patents and IP
Specific patent information not publicly detailed, but core IP centers on their discovery platform, genetic data, and novel crop traits
About Ross Hendron
Co-Founder and CEO of Wild Bioscience. Previously, he was an Entrepreneur in Residence at Oxford Science Enterprises and a Postdoctoral Research Scientist at the University of Oxford, specializing in plant genetics and bioinformatics. He holds a PhD in Plant Sciences from the University of Oxford.
Official website: https://www.wildbioscience.com